@misc{indiciae6313f2aeeb7f,
  title = {Successful IL-12 cancer immunotherapy requires NK cell-derived CCL5 for anti-tumor DC-T cell crosstalk},
  author = {Kirchhammer, N. and Trefny, M. P. and Natoli, M. and Bruecher, D. and Smith, S. N. and Werner, F. and Koch, V. and Schreiner, D. and Bartoszek, E. and Buchi, M. and Schmid, M. and Breu, D. and Hartmann, K. P. and Zaytseva, P. and Thommen, D. S. and Laubli, H. and Stanczak, M. A. and Kashyap, A. and Plueckthun, A. and Zippelius, A.},
  year = {2021},
  doi = {10.1101/2021.05.27.445981},
  url = {https://www.biorxiv.org/content/10.1101/2021.05.27.445981v1},
  note = {Source identifier: 10.1101/2021.05.27.445981}
}